Selective antigen-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selective antigen-specific T cells, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) [Phase 1]